Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityInterest DepositsLiabilities and Shareholders EquityLoans - Loss AllowanceLoans - NetLoans - NetLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecurities - TradableShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

First Keystone (FKYS) Cash & Equivalents (2023 - 2025)

First Keystone has reported Cash & Equivalents over the past 3 years, most recently at $121.2 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $121.2 million for Q4 2025, up 602.73% from a year ago — trailing twelve months through Dec 2025 was $121.2 million (up 602.73% YoY), and the annual figure for FY2025 was $121.2 million, up 602.73%.
  • Cash & Equivalents for Q4 2025 was $121.2 million at First Keystone, down from $147.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for FKYS hit a ceiling of $147.3 million in Q3 2025 and a floor of $12.3 million in Q1 2023.
  • Median Cash & Equivalents over the past 3 years was $17.1 million (2023), compared with a mean of $37.9 million.
  • Biggest five-year swings in Cash & Equivalents: grew 1.42% in 2024 and later surged 602.73% in 2025.
  • First Keystone's Cash & Equivalents stood at $17.0 million in 2023, then rose by 1.42% to $17.3 million in 2024, then surged by 602.73% to $121.2 million in 2025.
  • The last three reported values for Cash & Equivalents were $121.2 million (Q4 2025), $147.3 million (Q3 2025), and $39.1 million (Q2 2025) per Business Quant data.